Ideas

June 3, 2018

Published by admin_auro at June 3, 2018

Categories

Lifespan- and healthspan-extension therapy: Snai1/Snail, a protein that promotes epithelial to mesenchymal transition, may increase life span via up-regulation of its target gene BubR1 and others, 3/June/2018, 11.00 pm

What they say: Introduction: A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]

June 3, 2018

Published by admin_auro at June 3, 2018

Categories

Unknown action of a known drug in rescuing blood sugar disease: Bromocriptine-based adjunct therapy for autoimmune diabetes (TIDM): Bromocriptine (trade name:Parlodel), used in the treatment of pituitary tumors, Parkinson’s disease (PD), hyperprolactinaemia, infertility and others, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 3/June/2018, 7.32 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical […]

June 1, 2018

Published by admin_auro at June 1, 2018

Categories

Locking blood sugar disease with an interleukin therapy: Interleukin(IL-2)-based therapy for TIIDM: IL-2 increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 1/June/2018, 11.23 pm

Introduction: What they say: A study from the Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA shows that “The Lin28/let-7 axis […]

June 1, 2018

Published by admin_auro at June 1, 2018

Categories

Unknown action of a known drug in body weight control, energy homeostasis and TIIDM:Bromocriptine (trade name:Parlodel), used in the treatment of pituitary tumors, Parkinson’s disease (PD), hyperprolactinaemia, infertility and others, increases REV-ERB and its down stream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 1/June/2018, 11.14 pm

Introduction: What they say A study from the Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA shows that “Regulation of circadian behaviour […]